Ebos Group Limited (NZX: EBO) Half Year Results

Wednesday 17th February 2021

EBOS Group Limited today announced another record result for the first half of the 2021 financial year, including double-digit NPAT growth.

In today’s results announcement, EBOS Chief Executive Officer, John Cullity said: “It is pleasing to report another record profit for EBOS for the first half of FY21. Our double-digit earnings growth reflects a continuation of the strong first quarter momentum that we announced at our Annual Meeting in October 2020.”

“Both our Healthcare and Animal Care segments recorded very strong growth and contributed to the overall result. This again reinforces the strength of our diverse portfolio of businesses.”

Key highlights of the first half included:

• Revenue of $4.7 billion (up 6.3%);

• Statutory Net Profit after Tax (NPAT) of $92.9 million (up 13.7%);

• Underlying Net Profit after Tax (Underlying NPAT) of $94.3 million (up 14.2%);

• Interim dividend declared of NZ 42.5 cents per share (up 13.3%);

• Very strong performances from both our Healthcare and Animal Care segments, with Healthcare’s Underlying EBIT up 11.2% and Animal Care’s EBIT up 25.6%;

• Excellent operating cash flow of $98.7 million (up 33.0%);

• Acquisition of CH2’s vet distribution business for approximately $9 million, which further strengthens Lyppard’s market position in this sector. This adds to the previously announced acquisition of Cryomed, which further expands our medical devices business; and

• Further strengthening of our balance sheet, with Net Debt : EBITDA reducing to 1.00x (1.11x at June 2020). Following further refinancing initiatives in August 2020 and February 2021, EBOS has no debt maturities until 2H FY23.

Interim Dividend

The Directors declared an interim dividend of NZ 42.5 cents per share, an increase of 13.3% on the prior corresponding period. This implies a dividend payout ratio of 69.0%, broadly consistent with recent periods.

Please see the links below for details:

Media Release

Investor Presentation

Half Year Financial Statements

ASX Appendix 4D

NZX Results Announcement

NZX Distribution Notice

Directors' declaration

Shareholders report

Source: Ebos Group Limited

Comments from our readers

No comments yet